应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06127 昭衍新药
已收盘 06-12 16:08:21
16.420
+0.350
+2.18%
最高
16.760
最低
15.800
成交量
226.51万
今开
16.400
昨收
16.070
日振幅
5.97%
总市值
122.99亿
流通市值
19.54亿
总股本
7.49亿
成交额
3,715万
换手率
1.90%
流通股本
1.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
6月9日昭衍新药发生1笔大宗交易 成交金额1.28亿元
证券之星 · 06-09
6月9日昭衍新药发生1笔大宗交易 成交金额1.28亿元
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
金吾财讯 · 06-08
医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%
昭衍新药与中国科学院昆明动物研究所签署战略合作协议
第一财经 · 06-05
昭衍新药与中国科学院昆明动物研究所签署战略合作协议
昭衍新药授予316万股限制性股票 激励对象280人
财中社 · 06-05
昭衍新药授予316万股限制性股票 激励对象280人
昭衍新药(06127)将于8月4日派发末期现金股息每股0.13786港元
智通财经 · 06-04
昭衍新药(06127)将于8月4日派发末期现金股息每股0.13786港元
昭衍新药(06127):周冯源获委任为非执行董事
智通财经 · 06-04
昭衍新药(06127):周冯源获委任为非执行董事
昭衍新药宣派末期股息每股0.12元人民币,8月4日派发
公告速递 · 06-04
昭衍新药宣派末期股息每股0.12元人民币,8月4日派发
昭衍新药宣派末期股息每股0.12元,预计8月4日或之前派付
公告速递 · 06-04
昭衍新药宣派末期股息每股0.12元,预计8月4日或之前派付
昭衍新药更新5月股份变动月报表,股本维持稳定
公告速递 · 06-03
昭衍新药更新5月股份变动月报表,股本维持稳定
每周股票复盘:昭衍新药(603127)一周发生2笔大宗交易成交1.52亿
证券之星 · 05-31
每周股票复盘:昭衍新药(603127)一周发生2笔大宗交易成交1.52亿
4家CRO,减员5797人
赛柏蓝 · 05-27
4家CRO,减员5797人
智通AH统计|5月25日
智通财经 · 05-25
智通AH统计|5月25日
智通AH统计|5月22日
智通财经 · 05-22
智通AH统计|5月22日
5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元
证券之星 · 05-21
5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元
5月21日昭衍新药创60日新高,易方达医疗保健行业混合A基金重仓该股
证券之星 · 05-21
5月21日昭衍新药创60日新高,易方达医疗保健行业混合A基金重仓该股
昭衍新药早盘涨超7% 公司产能利用率维持在较高水平
新浪港股 · 05-21
昭衍新药早盘涨超7% 公司产能利用率维持在较高水平
异动快报:昭衍新药(603127)5月21日10点14分触及涨停板
证券之星 · 05-21
异动快报:昭衍新药(603127)5月21日10点14分触及涨停板
智通AH统计|5月20日
智通财经 · 05-20
智通AH统计|5月20日
食蟹猴供应仍然偏紧!昭衍新药一季度新签订单金额增长111.6%,核心业务亏损
红星资本局 · 05-20
食蟹猴供应仍然偏紧!昭衍新药一季度新签订单金额增长111.6%,核心业务亏损
芯片下沉,AI硬件全面开花
钛媒体 · 05-20
芯片下沉,AI硬件全面开花
加载更多
公司概况
公司名称:
昭衍新药
所属市场:
SEHK
上市日期:
--
主营业务:
北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":16.42,"timestamp":1781251701007,"preClose":16.07,"halted":0,"volume":2265115,"delay":0,"changeRate":0.02177971375233363,"floatShares":118995206,"shares":749000000,"eps":0.4,"marketStatus":"已收盘","change":0.35,"latestTime":"06-12 16:08:21","open":16.4,"high":16.76,"low":15.8,"amount":37148261,"amplitude":0.059739,"askPrice":16.42,"askSize":2600,"bidPrice":16.41,"bidSize":2400,"shortable":3,"etf":0,"ttmEps":0.775955,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":5,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":16.07,"dividendRate":0.008432,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0.949918,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":32.52,"timestamp":1781247600000,"preClose":31.39,"halted":0,"volume":19056400,"delay":0,"premium":"-56.42"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2642200466","title":"6月9日昭衍新药发生1笔大宗交易 成交金额1.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642200466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642200466?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:48","pubTimestamp":1780998517,"startTime":"0","endTime":"0","summary":"证券之星消息,6月9日昭衍新药发生大宗交易,交易数据如下:大宗交易成交价格29.8元,相对当日收盘价折价5.19%,成交429万股,成交金额12784.2万元,买方营业部为中信证券股份有限公司江苏分公司,卖方营业部为华泰证券股份有限公司太仓太平南路证券营业部。近三个月该股共发生13笔大宗交易,合计成交12.66万手,折价成交13笔。截至2026年6月9日收盘,昭衍新药报收于31.43元,上涨0.19%,换手率2.12%,成交量13.34万手,成交额4.16亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900029235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","06127","603127","BK1141","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示,2026年第一季度,海外CXO行业整体呈现分化复苏格局,全球生物制药融资环境出现实质性改善,带动需求逐步回暖,但早期初创企业资金压力仍未完全缓解,不同细分赛道、不同规模企业的表现存在差异,行业结构性分化特征进一步凸显。展望2026年,海外头部CXO企业收入指引仍维持稳健小幅增长格局,叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏,行业景气度延续上行态势,成长确定性进一步增强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0708995583.HKD","BK1521","BK1589","LU0516422366.SGD","BK1141","LU0051755006.USD","03759","LU0516422440.USD","HK0000306685.HKD","LU0516423091.SGD","HK0000320264.USD","LU0417516902.SGD","01548","LU0572944931.SGD","01521","LU0039217434.USD","LU2039709279.SGD","09939","06821","LU0326950275.SGD","LU1720050803.USD","BK1191","159938","LU0140636845.USD","02359","LU2242644610.SGD","LU3063872942.SGD","LU0417516738.SGD","LU0320764599.SGD","LU0348735423.USD","LU1688375341.USD","LU1880383366.USD","01873","LU0359201612.USD","02269","LU0307460666.USD","LU0856984785.SGD","LU0456827905.SGD","LU0516422952.EUR","LU2045819591.USD","LU1046422090.SGD","HK0000320223.HKD","SG9999002463.SGD","LU0348766576.USD","LU0348767384.USD","BK1574","LU0588546209.SGD","03347","BK1515","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641191007","title":"昭衍新药与中国科学院昆明动物研究所签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2641191007","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641191007?lang=zh_cn&edition=full","pubTime":"2026-06-05 11:30","pubTimestamp":1780630244,"startTime":"0","endTime":"0","summary":"近日,北京昭衍新药研究中心股份有限公司与中国科学院昆明动物研究所举行战略合作座谈会暨签约仪式,双方正式签署战略合作框架协议,围绕实验动物资源高值利用、重大疾病动物模型开发、数字生物医药、创新药研发与成果转化等领域开启全面、深度、长期合作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606053761716532.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606053761716532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603127","BK1141","BK0216","06127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641919514","title":"昭衍新药授予316万股限制性股票 激励对象280人","url":"https://stock-news.laohu8.com/highlight/detail?id=2641919514","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641919514?lang=zh_cn&edition=full","pubTime":"2026-06-05 08:46","pubTimestamp":1780620360,"startTime":"0","endTime":"0","summary":"6月4日,昭衍新药(603127/06127)发布公告,公司授予激励对象316万股A股限制性股票,授予价格为19.17元/股,激励对象人数为280人。2026年一季度,昭衍新药实现收入3.16亿元,归母净利润2.38亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606053761037769.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603127","BK1576","BK1141","06127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640716304","title":"昭衍新药(06127)将于8月4日派发末期现金股息每股0.13786港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2640716304","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640716304?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:37","pubTimestamp":1780583844,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昭衍新药(06127)发布公告,将于2026年8月4日派发截至2025年12月31日止年度的末期现金股息每股0.13786港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450435.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06127","VIG","EWH","603127","BK4585","BK4588","BK0216","BK1576","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640163089","title":"昭衍新药(06127):周冯源获委任为非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2640163089","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640163089?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:31","pubTimestamp":1780583488,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昭衍新药(06127)发布公告,有关委任周冯源先生为非执行董事的决议案已获股东于年度股东会上通过。周先生的任期自年度股东会之日起,并于第五届董事会届满时终止。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450432.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06127","BK1141","603127","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195641068","title":"昭衍新药宣派末期股息每股0.12元人民币,8月4日派发","url":"https://stock-news.laohu8.com/highlight/detail?id=1195641068","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195641068?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:30","pubTimestamp":1780583442,"startTime":"0","endTime":"0","summary":"北京昭衍新药研究中心股份有限公司发布末期股息更新公告,确认宣派截至2025年12月31日止年度的末期普通股息,每股派发0.12元人民币,折算为每股0.13786港元。该方案尚待2026年6月4日举行的股东大会批准。根据公告,股息除净日定于2026年6月22日,为符合获取股息分派而递交股份过户文件的最后时限为6月23日16时30分。股息预计在2026年8月4日派付。以非个人股东名义登记的H股股份均被视为非居民企业股东持有。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药宣派末期股息每股0.12元人民币,8月4日派发","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149194542","title":"昭衍新药宣派末期股息每股0.12元,预计8月4日或之前派付","url":"https://stock-news.laohu8.com/highlight/detail?id=1149194542","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149194542?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:27","pubTimestamp":1780583220,"startTime":"0","endTime":"0","summary":"昭衍新药公布,2025年度利润分配方案已获股东周年大会通过,将派发末期股息每股人民币0.12元(含税),按可参与分配的股份746,174,300股计算,派息总额约为8954.09万元人民币。股息以人民币向A股股东派付,以港元向H股股东派付。为厘定有权收取股息的H股股东名单,公司H股股东名册自2026年6月24日至6月26日暂停办理过户登记,记录日期为2026年6月26日。H股股东须不迟于6月23日下午4时30分完成过户,方可获派股息。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"昭衍新药宣派末期股息每股0.12元,预计8月4日或之前派付","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137413221","title":"昭衍新药更新5月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1137413221","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137413221?lang=zh_cn&edition=full","pubTime":"2026-06-03 15:01","pubTimestamp":1780470098,"startTime":"0","endTime":"0","summary":"北京昭衍新药研究中心股份有限公司于2026年6月3日发布了截至2026年5月31日的股份变动月报表。根据公告,报告期内无限售条件的H股和A股数量保持不变,公司股本结构与上月相比未发生变化。报告期内,公司未发生新增股份发行、股份购回、注销或股份期权及股权激励计划行权等变动。截至5月底,公司股本数额保持稳定。本次公告由公司联席公司秘书高大鹏签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639601946","title":"每周股票复盘:昭衍新药(603127)一周发生2笔大宗交易成交1.52亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2639601946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639601946?lang=zh_cn&edition=full","pubTime":"2026-05-31 01:38","pubTimestamp":1780162693,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘,昭衍新药(603127)报收于35.17元,较上周的41.35元下跌14.95%。本周,昭衍新药5月25日盘中最高价报42.99元。5月27日盘中最低价报34.4元。昭衍新药当前最新总市值263.55亿元,在医疗服务板块市值排名7/51,在两市A股市值排名810/5207。本周关注点来自交易信息汇总:5月27日昭衍新药发生2笔大宗交易,成交金额1.52亿元交易信息汇总5月27日昭衍新药发生2笔大宗交易,成交金额1.52亿元以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000284.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK0216","603127","06127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638507992","title":"4家CRO,减员5797人","url":"https://stock-news.laohu8.com/highlight/detail?id=2638507992","media":"赛柏蓝","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638507992?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:38","pubTimestamp":1779881880,"startTime":"0","endTime":"0","summary":"十家头部CRO企业员工总数从97918人增至98299人,增幅0.39%。表面看人数基本稳定,但内部差异化显著,药明康德、九洲药业、昭衍新药、毕得医药合计减少5797人;康龙化成、泰格医药、凯莱英仍在加人。01CRO扩员红利见顶2025年,国内头部CRO企业的人力扩张基本停了下来。两家公司一减一增,说明CRO人员扩张只会流向更明确的业务方向。此外,康龙化成在2026年一季度收入35.78亿元,同比增长15.48%;归母净利润3.35亿元,同比增长9.75%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-27/doc-inhzivfk8415193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06821","BK1191","BK1576","03347","06127","BK1141","03759","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638535260","title":"智通AH统计|5月25日","url":"https://stock-news.laohu8.com/highlight/detail?id=2638535260","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638535260?lang=zh_cn&edition=full","pubTime":"2026-05-25 16:15","pubTimestamp":1779696907,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止5月25日收盘,东北电气、浙江世宝、安德利果汁分列AH溢价率前三位,溢价率分别为610.53%、402.67%、321.80%;宁德时代、兆易创新、招商银行分列AH溢价率末三位,溢价率分别为-29.65%、-20.62%、-4.35%。其中大唐发电、安德利果汁、浙江世宝的偏离值位居前三,分别为82.87%、66.90%、53.24%;另外,上海电气、龙旗科技、京城机电股份的偏离值位居后三,分别为-33.54%、-17.88%、-17.86%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445579.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01812","06031","06127","399300","80883","09611","HPAD.SI","01800","03986","02601","EWH","00883","02359","01171","82318","00991","PNGAY","00916","03145","02318","LU1115378108.SGD","00187","01033","03143","06613","601318","01108","02899","03296","00300","02218","00719","00042","02338","03678","01057","01349","PAImain","00956","00895","03968","01276","159982","02628","LU0651947912.USD","00553","02727","00981","03750"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637391065","title":"智通AH统计|5月22日","url":"https://stock-news.laohu8.com/highlight/detail?id=2637391065","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637391065?lang=zh_cn&edition=full","pubTime":"2026-05-22 16:15","pubTimestamp":1779437706,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止5月22日收盘,东北电气、浙江世宝、弘业期货分列AH溢价率前三位,溢价率分别为610.53%、386.64%、304.56%;宁德时代、兆易创新、招商银行分列AH溢价率末三位,溢价率分别为-28.21%、-27.83%、-4.15%。其中大唐发电、东北电气、浙江世宝的偏离值位居前三,分别为86.78%、45.81%、39.50%;另外,上海电气、龙旗科技、东江环保的偏离值位居后三,分别为-34.55%、-20.97%、-16.41%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445017.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00981","02628","PNGAY","00187","03678","01057","02338","00883","03986","03296","00553","00501","EWH","02727","02899","IE0008369823.USD","00895","03750","80883","01800","00042","02359","02691","03145","06613","HPAD.SI","601318","01276","09611","PAImain","01349","159982","03143","06127","03968","01033","00300","02476","399300","06031","82318","01812","01108","00956","02318","00916","01171","02218","00991"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637381642","title":"5月21日昭衍新药现10笔大宗交易 机构净买入735.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637381642","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637381642?lang=zh_cn&edition=full","pubTime":"2026-05-21 17:48","pubTimestamp":1779356918,"startTime":"0","endTime":"0","summary":"证券之星消息,5月21日昭衍新药发生大宗交易,交易数据如下:近三个月该股共发生10笔大宗交易,合计成交4.02万手,折价成交10笔。该股近期无解禁股上市。截至2026年5月21日收盘,昭衍新药报收于42.77元,上涨10.01%,涨停,换手率9.63%,成交量60.71万手,成交额25.52亿元。该股近半年内有股东持股变动,合计净减持487.53万股,股东增减持明细如下表:该股最近90天内共有8家机构给出评级,买入评级7家,增持评级1家;过去90天内机构目标均价为44.32。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100033117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK1141","BK0216","06127","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637740383","title":"5月21日昭衍新药创60日新高,易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2637740383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637740383?lang=zh_cn&edition=full","pubTime":"2026-05-21 16:27","pubTimestamp":1779352067,"startTime":"0","endTime":"0","summary":"证券之星消息,5月21日昭衍新药涨10.01%创60日新高,收盘报42.77元,换手率9.63%,成交量60.71万手,成交额25.52亿元。根据2026基金Q1季报公募基金重仓股数据,重仓该股的公募基金共44家,其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为32.51亿元,最新净值3.742,较上一交易日上涨0.38%,近一年上涨6.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100030309.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","BK1576","06127","BK0216","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637036028","title":"昭衍新药早盘涨超7% 公司产能利用率维持在较高水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2637036028","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637036028?lang=zh_cn&edition=full","pubTime":"2026-05-21 10:40","pubTimestamp":1779331200,"startTime":"0","endTime":"0","summary":" 昭衍新药早盘涨超7%,截至发稿,股价上涨7.08%,现报21.02港元,成交额7631.46万港元。 据昭衍新药披露数据显示,昭衍新药2026年第一季度实现新签订单金额约9.1亿元,同比增长111.6%;截至一季度末,公司在手订单储备规模为31亿元,同比增长40.9%。公司在业绩说明会上透露,截至目前,第二季度订单的量价水平整体延续一季度态势。公司产能利用率维持在较高水平,但仍具备一定释放弹性,可灵活承接后续新增订单。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-05-21/doc-inhyrmmr6436557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06127","BK1576","BK1141","BK0216","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637489808","title":"异动快报:昭衍新药(603127)5月21日10点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2637489808","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637489808?lang=zh_cn&edition=full","pubTime":"2026-05-21 10:15","pubTimestamp":1779329728,"startTime":"0","endTime":"0","summary":"证券之星5月21日盘中消息,10点14分昭衍新药触及涨停板。其所属行业医疗服务目前上涨。该股为健康中国,CAR-T疗法,创新药概念热股,当日健康中国概念上涨1.95%,CAR-T疗法概念上涨1.85%,创新药概念上涨1.77%。5月20日的资金流向数据方面,主力资金净流出4624.47万元,占总成交额3.85%,游资资金净流入790.48万元,占总成交额0.66%,散户资金净流入3833.99万元,占总成交额3.19%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100013614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1141","603127","BK1576","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636814105","title":"智通AH统计|5月20日","url":"https://stock-news.laohu8.com/highlight/detail?id=2636814105","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636814105?lang=zh_cn&edition=full","pubTime":"2026-05-20 16:15","pubTimestamp":1779264907,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,截止5月20日收盘,东北电气、浙江世宝、弘业期货分列AH溢价率前三位,溢价率分别为583.54%、378.80%、325.76%;宁德时代、兆易创新、药明康德分列AH溢价率末三位,溢价率分别为-25.01%、-24.34%、-4.49%。其中安德利果汁、南华期货股份、新天绿色能源的偏离值位居前三,分别为59.87%、39.10%、37.43%;另外,上海电气、龙旗科技、中国交通建设的偏离值位居后三,分别为-36.77%、-22.21%、-16.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443916.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01800","02691","09611","PAImain","01108","02318","02359","IE00BPRC5H50.USD","01812","02338","03145","00187","01339","LU1242518857.USD","03678","03986","LU1960683339.HKD","HPAD.SI","82318","03296","03143","03328","06031","02218","03968","02727","01057","02628","00568","02880","PNGAY","01033","159982","00895","00300","01349","00553","00042","06613","06127","01288","399300","EWH","02476","601318","01276","00956","03750","00638"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636897358","title":"食蟹猴供应仍然偏紧!昭衍新药一季度新签订单金额增长111.6%,核心业务亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2636897358","media":"红星资本局","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636897358?lang=zh_cn&edition=full","pubTime":"2026-05-20 11:36","pubTimestamp":1779248205,"startTime":"0","endTime":"0","summary":"红星资本局5月20日消息,5月19日,“猴茅”昭衍新药(603127.SH;06127.HK)召开2026年第一季度业绩说明会,就投资者关心的业绩表现、订单情况、实验猴价格趋势等问题进行了回应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743242061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["603127","BK1141","06127","BK0216","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636950858","title":"芯片下沉,AI硬件全面开花","url":"https://stock-news.laohu8.com/highlight/detail?id=2636950858","media":"钛媒体","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636950858?lang=zh_cn&edition=full","pubTime":"2026-05-20 08:28","pubTimestamp":1779236880,"startTime":"0","endTime":"0","summary":"端侧AI芯片是全球半导体行业增长最迅猛的板块之一,AI眼镜、AI耳机、AI玩具等新兴硬件品类对端侧芯片有着强劲需求。可以说,没有这些芯片厂商的技术突破和成本下探,就没有AI硬件的万亿叙事。这一判断的实践落地,在2026年的芯片端得到了全面回应。当这两条路线同时在芯片层面得到实现,AI硬件的临界点才真正到来。以Plaud为代表的AI录音硬件年营收达2.5亿美元,连续两年实现10倍增长,全球销量已突破百万台规模。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8tH431vOMtq","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["300458","BK4588","06127","603893","603127","BK4585","688012","QCOM","BK4535"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0775},{"period":"1month","weight":-0.2289},{"period":"3month","weight":-0.1738},{"period":"6month","weight":-0.2448},{"period":"1year","weight":0.0691},{"period":"ytd","weight":-0.2199}],"compareEarnings":[{"period":"1week","weight":-0.0398},{"period":"1month","weight":-0.0797},{"period":"3month","weight":-0.0478},{"period":"6month","weight":-0.0665},{"period":"1year","weight":-0.0048},{"period":"ytd","weight":-0.0539}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.052832},{"month":2,"riseRate":0.6,"avgChangeRate":0.086342},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.020364},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.075609},{"month":5,"riseRate":0.666667,"avgChangeRate":0.065541},{"month":6,"riseRate":0.5,"avgChangeRate":0.038343},{"month":7,"riseRate":0.8,"avgChangeRate":0.10434},{"month":8,"riseRate":0,"avgChangeRate":-0.152531},{"month":9,"riseRate":0.6,"avgChangeRate":0.016217},{"month":10,"riseRate":0.2,"avgChangeRate":-0.062992},{"month":11,"riseRate":0.4,"avgChangeRate":0.019594},{"month":12,"riseRate":0.6,"avgChangeRate":0.001916}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}